Guizhou Salvage Pharmaceutical Co.,Ltd. (600227.SS)
CNY 2.74
(-1.43%)
CNY 2.74
(-1.43%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 307.99 Million | 195.61 Million | 276.66 Million | 264.55 Million | 140.09 Million | 523.34 Million |
| Net Income | -123.97 Million | -371.48 Million | -56.64 Million | 52.37 Million | -1.71 Billion | 198.23 Million |
| Depreciation & Amortization | 196.03 Million | 177.87 Million | 179.44 Million | 171.8 Million | 262.78 Million | 284.92 Million |
| Deferred income taxes | 70 Million | 4.58 Million | -13.92 Million | -8.14 Million | -10.88 Million | -6.2 Million |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 252.81 Million | 190.29 Million | 22.28 Million | -103.5 Million | -193.1 Million | -92.9 Million |
| Other non-cash items | 42.56 Million | 198.92 Million | 131.58 Million | 143.88 Million | 1.78 Billion | 133.09 Million |
| Investing Cash Flow | -224.93 Million | -444.55 Million | -180.79 Million | -105.05 Million | -11.44 Million | 66.07 Million |
| Investments in PPE | -203.11 Million | -451.06 Million | -202.35 Million | -109.51 Million | -105.37 Million | -158.71 Million |
| Acquisitions | -7.35 Million | 5 Million | 1.39 Million | 3.1 Million | 147.66 Million | -476.76 Thousand |
| Investment purchases | -15 Million | -5 Million | -1.39 Million | -3.1 Million | -9.5 Million | 542.2 Thousand |
| Sales/Maturities of investments | 694.17 Thousand | 1.5 Million | 269.95 Thousand | 1.34 Million | 61.13 Million | 72 Million |
| Other Investing Activities | -7.74 Million | 5 Million | 21.28 Million | 3.1 Million | -105.37 Million | 152.72 Million |
| Financing Cash Flow | -21.69 Million | 225.31 Million | -39.37 Million | -232.23 Million | -308.04 Million | -690.79 Million |
| Debt repayment | -26.2 Million | -271.8 Million | -387.41 Million | -541.57 Million | -596.23 Million | -1.14 Billion |
| Dividends payments | -42.88 Million | -20.05 Million | -19.79 Million | -31.45 Million | -44.82 Million | -54.36 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -5.02 Million | 517.17 Million | 367.83 Million | 340.79 Million | 333.02 Million | 507.4 Million |
| Accounts receivables | 979.16 Million | -87.62 Million | 265.95 Million | -146.48 Million | -59.12 Million | -175.22 Million |
| Accounts payables | -864.6 Million | 202.48 Million | 6.84 Million | 21.56 Million | -129.09 Million | 40.24 Million |
| Inventory | 68.26 Million | 70.84 Million | -236.59 Million | 29.55 Million | 6 Million | 49.98 Million |
| Other working capital | -794.6 Million | 4.58 Million | -13.92 Million | -8.14 Million | -10.88 Million | -142.89 Million |
| Cash at beginning of period | 65.81 Million | 89.43 Million | 32.93 Million | 105.67 Million | 285.06 Million | 386.43 Million |
| Cash at end of period | 127.17 Million | 65.81 Million | 89.43 Million | 32.93 Million | 105.67 Million | 285.06 Million |
| Capital Expenditure | -203.11 Million | -451.06 Million | -202.35 Million | -109.51 Million | -105.37 Million | -158.71 Million |
| Effect of forex changes on cash | - | - | - | - | 0.34 | - |
| Net cash flow / Change in cash | 61.35 Million | -23.61 Million | 56.49 Million | -72.73 Million | -179.39 Million | -101.37 Million |
| Free Cash Flow | 104.87 Million | -255.44 Million | 74.31 Million | 155.04 Million | 34.72 Million | 364.63 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 2.12 Million | 3.43 Million | -40.18 Million | 126.67 Million | -123.97 Million | -87.24 Million |
| Depreciation & Amortization | - | 57.91 Million | 57.91 Million | 196.03 Million | 196.03 Million | -91.34 Million |
| Deferred income taxes | - | - | - | - | 70 Million | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | -145.85 Million | - | 1.04 Billion | 252.81 Million | -37.16 Million |
| Other non-cash items | 197.56 Million | 171.36 Million | 21.13 Million | -1.22 Billion | 42.56 Million | 349.48 Million |
| Investing Cash Flow | -29.79 Million | -38.97 Million | -87.41 Million | -39.99 Million | -224.93 Million | -64.14 Million |
| Investments in PPE | -30.37 Million | -38.97 Million | -87.36 Million | -32.48 Million | -203.11 Million | -64.94 Million |
| Acquisitions | - | - | - | -7.5 Million | -7.35 Million | 107.56 Thousand |
| Investment purchases | - | - | -50 Thousand | - | -15 Million | - |
| Sales/Maturities of investments | - | - | - | - | 694.17 Thousand | - |
| Other Investing Activities | 578.47 Thousand | - | -50 Thousand | -7.58 Million | -7.74 Million | 694.17 Thousand |
| Financing Cash Flow | -65.49 Million | -64.92 Million | 24.05 Million | -86.96 Million | -21.69 Million | -40.81 Million |
| Debt repayment | -51.06 Million | -39.72 Million | -42.86 Million | -61.89 Million | -26.2 Million | -204 Million |
| Dividends payments | -10.41 Million | -12.15 Million | -11.61 Million | -25.06 Million | -42.88 Million | -5.24 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -4.01 Million | -13.04 Million | -7.19 Million | -9985.47 | -5.02 Million | 168.42 Million |
| Accounts receivables | - | -178.31 Million | - | 979.16 Million | 979.16 Million | 44.46 Million |
| Accounts payables | - | - | - | - | -864.6 Million | - |
| Inventory | - | 32.46 Million | - | 68.26 Million | 68.26 Million | -81.63 Million |
| Other working capital | - | - | - | - | - | - |
| Cash at beginning of period | 57.75 Million | 44.76 Million | 127.17 Million | 107.23 Million | 65.81 Million | 79.16 Million |
| Cash at end of period | 161.58 Million | 57.75 Million | 44.76 Million | 127.17 Million | 127.17 Million | 107.23 Million |
| Capital Expenditure | -30.37 Million | -38.97 Million | -87.36 Million | -32.48 Million | -203.11 Million | -64.94 Million |
| Effect of forex changes on cash | - | - | - | - | - | -694.17 Thousand |
| Net cash flow / Change in cash | 103.82 Million | 12.98 Million | -82.4 Million | 19.93 Million | 61.35 Million | 28.06 Million |
| Free Cash Flow | 169.32 Million | 77.91 Million | -106.41 Million | 114.69 Million | 104.87 Million | 68.78 Million |
5186
GWW
FEDFINA
AOT
OPTI
PRS